NDC Directory Finished Products
Table of FINISHED Products
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | RxNorm | Status | |
|---|---|---|---|---|---|---|---|---|
| 0074-7095 | Qulipta | Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7096 | Qulipta | Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7098 | Vuity | Pilocarpine Hydrochloride | Solution/ Drops | Ophthalmic | Abbvie Inc. | ACTIVE | ||
| 0074-7148 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7149 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7325 | Depakote | Divalproex Sodium | Tablet, Delayed Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7326 | Depakote | Divalproex Sodium | Tablet, Delayed Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7327 | Depakote | Divalproex Sodium | Tablet, Delayed Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7401 | Depakote ER | Divalproex Sodium | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7402 | Depakote ER | Divalproex Sodium | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-8300 | Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | ||
| 0074-8350 | Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | ||
| 0074-9036 | Zemplar | Paricalcitol | Capsule, Liquid Filled | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-9037 | Zemplar | Paricalcitol | Capsule, Liquid Filled | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-9296 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-9694 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0075-0620 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0621 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0622 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0623 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0624 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0626 | Lovenox | Enoxaparin Sodium | Injection | Intravenous; Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-2912 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-2915 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8013 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8014 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8016 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8018 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8020 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8022 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8025 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8030 | Lovenox | Enoxaparin Sodium | Injection | Intravenous; Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0078-0109 | Sandimmune | Cyclosporine | Injection | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0180 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0181 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0182 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0240 | Sandimmune | Cyclosporine | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0241 | Sandimmune | Cyclosporine | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0246 | Neoral | Cyclosporine | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0248 | Neoral | Cyclosporine | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0249 | Femara | Letrozole | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0274 | Neoral | Cyclosporine | Solution | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0314 | Diovan Hct | Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0315 | Diovan Hct | Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0331 | Simulect | Basiliximab | Injection, Powder, For Solution | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0337 | Trileptal | Oxcarbazepine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0357 | Trileptal | Oxcarbazepine | Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0358 | Diovan | Valsartan | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0359 | Diovan | Valsartan | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0360 | Diovan | Valsartan | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0364 | Lotrel | Amlodipine Besylate And Benazepril Hydrochloride | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0370 | Ritalin LA | Methylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0371 | Ritalin LA | Methylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0372 | Ritalin LA | Methylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0379 | Lotrel | Amlodipine Besylate And Benazepril Hydrochloride | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0383 | Diovan Hct | Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0385 | Myfortic | Mycophenolic Acid | Tablet, Delayed Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0386 | Myfortic | Mycophenolic Acid | Tablet, Delayed Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0393 | Simulect | Basiliximab | Injection, Powder, For Solution | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0401 | Gleevec | Imatinib Mesylate | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0405 | Lotrel | Amlodipine Besylate And Benazepril Hydrochloride | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0406 | Lotrel | Amlodipine Besylate And Benazepril Hydrochloride | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0414 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0415 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0417 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0422 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0423 | Diovan | Valsartan | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0424 | Ritalin LA | Methylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0430 | Focalin XR | Dexmethylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0431 | Focalin XR | Dexmethylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0432 | Focalin XR | Dexmethylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0433 | Focalin XR | Dexmethylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0434 | Focalin XR | Dexmethylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0439 | Ritalin | Methylphenidate Hydrochloride | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0440 | Ritalin | Methylphenidate Hydrochloride | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0441 | Ritalin | Methylphenidate Hydrochloride | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0456 | Trileptal | Oxcarbazepine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0457 | Trileptal | Oxcarbazepine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0467 | Desferal | Deferoxamine Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0468 | Exjade | Deferasirox | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0469 | Exjade | Deferasirox | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0470 | Exjade | Deferasirox | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0471 | Diovan Hct | Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0472 | Diovan Hct | Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0488 | Exforge | Amlodipine Besylate And Valsartan | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0489 | Exforge | Amlodipine Besylate And Valsartan | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0490 | Exforge | Amlodipine Besylate And Valsartan | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0491 | Exforge | Amlodipine Besylate And Valsartan | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0493 | Focalin XR | Dexmethylphenidate Hydrochloride | Capsule, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0501 | Exelon | Rivastigmine | Patch, Extended Release | Transdermal | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0502 | Exelon | Rivastigmine | Patch, Extended Release | Transdermal | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0503 | Exelon | Rivastigmine | Patch, Extended Release | Transdermal | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0508 | Tegretol | Carbamazepine | Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0509 | Tegretol | Carbamazepine | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0510 | Tegretol XR | Carbamazepine | Tablet, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0511 | Tegretol XR | Carbamazepine | Tablet, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0512 | Tegretol XR | Carbamazepine | Tablet, Extended Release | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0526 | Tasigna | Nilotinib | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0559 | Exforge Hct | Amlodipine Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0560 | Exforge Hct | Amlodipine Valsartan And Hydrochlorothiazide | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE |
TOTAL FINISHED PRODUCTS: 115,152
TOTAL FINISHED PRODUCTS BY TYPE
HUMAN PRESCRIPTION DRUG PRODUCTS: 56,304
HUMAN OTC DRUG PRODUCTS: 56,056
NON-STANDARDIZED ALLERGENIC PRODUCTS: 2,197
PLASMA DERIVATIVE PRODUCTS: 318
VACCINE PRODUCTS: 131
STANDARDIZED ALLERGENIC PRODUCTS: 123
CELLULAR THERAPY PRODUCTS: 23